Team Leader

* Due to the reorganization starting as new centers in April 2018, this laboratory is now belong to the Center for Integrative Medical Sciences. As for the latest information, please see the following URL below.
> The webpage of Laboratory for Cellular Function Conversion Technology, Center for Integrative Medical Sciences
Team Leader
Harukazu Suzuki
1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, JAPAN
We will develop technologies for direct cell conversion to target cell types of potential therapeutic interest, based on the integrated knowledge of the transcriptome status, the transcriptional basins, the epigenome, and the non-coding RNA, including technologies for high efficient, loci specific epigenome modification. Linked to the direct cell conversion, differentiation and safety of stem cells will be explored. We also aim at application of the transcriptional regulatory network analysis technologies to wide variety of biological sresearch.
CLST was reorganized into three centers according to the RIKEN 4th Medium-Term Plan from April 1, 2018. For the latest information of Cellular Function Conversion Technology Team, please visit the following websites.
> The webpage of Laboratory for Cellular Function Conversion Technology, Center for Integrative Medical Sciences [http://www.ims.riken.jp/labo/65/index.html]
> If you continue to browse this site, click here.